Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications
Outcomes and Safety of CAR-T Cell Therapy in B-NHL Patients With Reduced Left Ventricular Ejection Fraction.
Journal: Transplantation and cellular therapy
Published: March 27, 2026
Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
Pan-tumor spatial transcriptomics reveals conserved properties of tumor organization.
Journal: Cell reports. Medicine
Published: December 12, 2025
Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma.
Journal: Future oncology (London, England)
Published: December 10, 2025
NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 09, 2025
Potentiating CAR-T bystander killing by enhanced Fas/FasL signaling mitigates antigen escape in heterogeneous tumors.
Journal: bioRxiv : the preprint server for biology
Published: October 03, 2025
Targeting BCMA in Plasmablastic Lymphoma With Teclistamab: A Case Study of Three Patients.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 17, 2025
Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025
Low-Strength Type I Interferon Signaling Promotes CAR T Cell Treatment Efficacy.
Journal: Cancer immunology research
Published: June 03, 2025
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL.
Journal: Blood advances
Published: May 13, 2025
Two-Stage CD8+ CAR T-Cell Differentiation in Patients with Large B-Cell Lymphoma.
Journal: bioRxiv : the preprint server for biology
Published: March 31, 2025
Last Updated: 09/26/2026